Table 2.
Sensitivity analysis excluding probiotic infants
| Pre-COVID-19 group (n = 8,735) | COVID-19 group (n = 3,773) | p value | |
|---|---|---|---|
| NEC, n (%) | 170 (2.0) | 57 (1.5) | 0.09 |
| Surgical NEC, n (%) | 66 (0.8) | 29 (0.8) | 0.93 |
| LOS, n (%) | 361 (4.1) | 108 (2.9) | 0.001 |
Sensitivity analysis excluding probiotic infants
| Pre-COVID-19 group (n = 8,735) | COVID-19 group (n = 3,773) | p value | |
|---|---|---|---|
| NEC, n (%) | 170 (2.0) | 57 (1.5) | 0.09 |
| Surgical NEC, n (%) | 66 (0.8) | 29 (0.8) | 0.93 |
| LOS, n (%) | 361 (4.1) | 108 (2.9) | 0.001 |